PROTHENA CORPORATION PUBLIC LIMITED COMPANY Current Liabilities
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Current Liabilities of $11.66 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $11.66M.
- 2026-03-31: Liabilities, Current $32.52M.
- 2025-12-31: Liabilities, Current $40.84M.
- 2025-09-30: Liabilities, Current $51.44M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $11.66M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $32.52M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $40.84M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $51.44M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $67.81M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $48.46M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $48.50M 10-K · filed 2026-02-27 |
| 2024-09-30 | $46.42M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $46.74M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $43.27M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $56.89M 10-K · filed 2025-02-27 |
| 2023-09-30 | $53.37M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $71.56M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $48.88M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $50.15M 10-K · filed 2024-02-22 |
| 2022-09-30 | $50.60M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $40.11M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $36.50M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $33.45M 10-K · filed 2023-02-28 |
| 2021-09-30 | $29.20M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $52.90M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $23.46M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $25.85M 10-K · filed 2022-02-25 |
| 2020-09-30 | $21.72M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $18.54M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $17.09M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $17.71M 10-K · filed 2021-02-26 |
| 2019-09-30 | $31.76M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $28.02M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $14.91M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $14.93M 10-K · filed 2020-03-03 |
| 2018-09-30 | $23.63M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $46.13M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $35.55M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $37.37M 10-K · filed 2019-03-15 |
| 2017-09-30 | $39.26M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $39.60M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $33.68M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $41.08M 10-K · filed 2018-02-26 |
| 2016-09-30 | $36.91M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $33.46M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $23.23M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $22.22M 10-K · filed 2017-02-27 |
| 2015-09-30 | $18.56M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $13.46M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $9.54M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $12.04M 10-K · filed 2016-02-25 |
| 2014-09-30 | $9.97M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $11.31M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $8.96M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $7.41M 10-K · filed 2015-03-13 |
| 2013-09-30 | $7.71M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $9.08M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $5.09M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $1.74M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |